New York, New York-- (Newsfile Corp. - April 24, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Viatris Inc. (NASDAQ: VTRS) and certain ...

Shares of Viatris Inc. VTRS rose 1.56% to $7.81 Wednesday, on what proved to be an all-around great trading session for the ...

We recently published a list of the 10 Best Cheap Stocks to Buy Under $10. In this article, we are going to take a look at ...

Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Viatris Inc. (NASDAQ: VTRS) securities between August 8, 2024 and February ...

(Reuters) -Viatris said on Monday it would pay up to $335 million over nine years as part of a nationwide settlement to resolve claims by U.S. state and local governments that it fueled an epidemic of ...

Viatris Inc. (Nasdaq: VTRS) today announced that Hemanth J. Varghese has joined the Company as Chief Strategy Officer.

Viatris seeks Japan’s MHLW approval for Effexor SR capsules to treat generalized anxiety disorder: Pittsburgh Tuesday, April 22, 2025, 13:00 Hrs [IST] Viatris Inc., a global hea ...

(RTTNews) - Viatris Inc. (VTRS), a healthcare company, Monday said it has submitted Supplemental New Drug Application to Japan's Ministry of Health, Labor and Welfare (MHLW) for Effexor to treat ...

Learn more about whether Ligand Pharmaceuticals Incorporated or Viatris Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Shares of Viatris Inc. VTRS advanced 1.59% to $7.69 Tuesday, on what proved to be an all-around great trading session for the ...

PITTSBURGH, April 14, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) today announced that Hemanth J. Varghese has joined the Company as Chief Strategy Officer. Varghese will be a member of the ...